Peri-implantitis Market Growth & Trends
The global peri-implantitis market size is expected to reach USD 1.3 billion by 2027, expanding at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%–98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.
The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.
Request a sample copy of the Peri-implantitis Market Research Report @ https://www.grandviewresearch.com/industry-analysis/peri-implantitis-market/request/rs1
Peri-implantitis Market Report Highlights
- The surgical segment dominated the market in 2019 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
- Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
- Europe dominated the market in 2019 owing to the rising technological advancements for peri-implantitis treatment
- In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/451002/ibb
Peri-implantitis Market Segmentation
Grand View Research has segmented the global peri-implantitis market on the basis of method type and region:
Peri-implantitis Method Type Outlook (Revenue, USD Million, 2016 – 2027)
- Bone Regeneration
- Open Flap Debridement
- Mechanical Debridement
- Laser Debridement
Peri-implantitis Regional Outlook (Revenue, USD Million, 2016 – 2027)
- South Korea
Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players of Peri-implantitis Market
- Pfizer Inc.
- Cadila Pharmaceuticals
- R.N. Laboratories Pvt. Ltd.
- Basic Pharma Life Science Pvt. Ltd.
- Prachi Pharmaceuticals Private Limited.
- Geistlich Pharma Inc.
- Healthy Life Pharma
Browse Related Report:
Dental Turbine Market : https://www.grandviewresearch.com/industry-analysis/dental-turbine-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States